Giuseppe Giaccone
Physician · New York-Presbyterian/Queens
Credentials: · · · · ·
History
2025–Present
- 1983–1986
Hematology and Medical Oncology
- 1980–1983
Internal Medicine
Vrije University Medical Center
Research
Journal of Clinical Oncology · 2003 · 2,429 citations
Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs
JAMA · 2014 · 1,437 citations
Atezolizumab for First-Line Treatment of PD-L1-Selected Patients with NSCLC
New England Journal of Medicine · 2020 · 1,378 citations
50 papers
- AT
29 papers
- RK
18 papers · 11 as a fellow
18 papers
- CC
16 papers
13 papers · 5 as a fellow
- DS
13 papers
- FD
13 papers · 6 as a resident
Grants
- 1997–2024
Georgetown University Lombardi Comprehensive Cancer Center Support Grant
National Cancer Institute · P30
Project lead · $330K · Georgetown University
National Cancer Institute · ZID
Contact PI · $21.8M · Division of Basic Sciences - Nci
National Cancer Institute · ZID
Contact PI · $13.8M · Division of Basic Sciences - Nci
Thoracic Cancer Research Laboratory
National Cancer Institute · ZIA
Contact PI · $5.4M · Division of Basic Sciences - Nci
Clinical trials
- 2015–2021
Pembrolizumab and Epacadostat in Patients With Thymic Carcinoma
Principal investigator · Unknown · Phase 2
Georgetown University
- 2014–2016
A Phase I/II Study of Ganetespib in Combination With Doxorubicin
Principal investigator · Terminated · Phase 1, Phase 2
Georgetown University
- 2011–2018
Principal investigator · Terminated · Phase 2
Tiziana Life Sciences LTD
- 2010–2012
Principal investigator · Completed · Phase 1, Phase 2
National Cancer Institute (NCI)